Skip to main navigation

News
Events
Careers
Investors
Compliance

Site - Corporate Menu

Healthcare Professionals
Patients & Caregivers
About Atricure

Home
Investors
News Releases

News Releases

Site - Corporate Menu - Mobile

Healthcare Professionals
Patients & Caregivers
About AtriCure

Investor Relations

Investor Overview
Corporate Governance
Financial Information
Stock Information
News Releases
Events
Contact Us
E-mail Alerts

News Releases

News Releases

Keyword Search

News Category

Year

01/13/25

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day

MASON, Ohio --(BUSINESS WIRE)--Jan. 13, 2025-- AtriCure, Inc. (Nasdaq: ATRC) , a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced preliminary financial results for the

Shareholder Tools

Print Page
RSS Feeds
E-mail Alerts

Please note that after clicking Agree, you will leave this website to view content on another website. The Terms and Conditions of other websites may differ from those of atricure.com.

About AtriCure

Site - About Atricure

Overview
Careers
News
Investors
History & Timeline
Locations
Management
Board of Directors

More Information

Site - More Information

Contact Us
Compliance
UK Slavery Act
Terms of Use
Privacy Notice
Site Map

International

Site - International menu

Overview
News
Clinical Trials
Contact Us

© 2025 Atricure, Inc. All Rights Reserved.

Site - Corporate Menu

Healthcare Professionals
Patients & Caregivers
About Atricure

More Information Compliance UK Slavery Act Terms of Use Privacy Notice Site Map

CONTACT US >